KIAA0528 (C2CD5) (NM_001286176) Human Untagged Clone

CAT#: SC337812

C2CD5 (untagged) - Human C2 calcium-dependent domain containing 5 (C2CD5), transcript variant 1



  "NM_001286176" in other vectors (2)

CNY 10170.00


货期*
5周

规格
    • 10 ug

Product images

推荐一起购买 (4)
C2CD5 Antibody - N-terminal region
    • 100 ul

CNY 5250.00


TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms CDP138; KIAA0528
Vector pCMV6-Entry
E. coli Selection Kanamycin (25 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
>NCBI ORF sequence for NM_001286176, the custom clone sequence may differ by one or more nucleotides


ATGCCAGGGAAGCTGAAGGTGAAAATCGTGGCCGGGCGCCATTTGCCAGTGATGGACCGTGCTAGTGACC
TGACTGATGCCTTCGTGGAGGTAAAATTTGGTAATACCACCTTTAAAACAGATGTGTACCTTAAGTCACT
CAACCCTCAGTGGAACTCGGAGTGGTTTAAATTTGAGGTGGATGATGAAGACTTACAAGATGAACCTTTA
CAGATCACAGTTCTTGACCATGATACTTACAGTGCAAATGATGCCATTGGTAAAGTGTACATTGATATTG
ATCCTTTACTGTATAGTGAAGCTGCAACAGTCATCTCAGGATGGTTTCCAATTTATGACACCATACATGG
TATCCGTGGGGAAATCAATGTAGTTGTCAAAGTAGACCTCTTCAATGATTTAAATCGATTTAGGCAGTCA
TCATGTGGAGTCAAATTCTTTTGCACAACGTCTATTCCAAAATGCTATAGAGCTGTGATAATTCATGGAT
TTGTAGAAGAACTTGTGGTCAATGAAGACCCAGAATATCAGTGGATTGATCGAATTCGCACACCAAGGGC
ATCAAATGAGGCCAGACAGAGACTCATTTCGTTAATGTCAGGTGAGCTGCAGAGGAAGATTGGCTTGAAA
GTACTTGAAATGAGAGGAAATGCAGTTGTGGGGTACTTACAGTGTTTCGATCTGGAGGGCGAGTCTGGGT
TAGTGGTGCGAGCCATAGGAACGGCGTGTACTCTGGATAAATTAAGTAGCCCAGCAGCATTCCTTCCTGC
ATGTAATTCCCCATCCAAAGAAATGAAGGAGATTCCCTTCAATGAAGATCCCAATCCCAATACTCACTCA
TCAGGACCCTCAACCCCTCTGAAAAACCAAACTTATTCCTTTTCACCTTCCAAGTCCTACAGTCGACAGT
CCTCTTCTTCTGACACAGATTTGAGTTTGACACCCAAAACTGGAATGGGAAGTGGTAGTGCTGGAAAAGA
AGGGGGGCCCTTTAAAGCTCTTTTAAGACAACAGACTCAATCAGCGTTGGAACAGAGGGAATTTCCATTT
TTTACCTTGACGGCATTTCCTCCTGGATTCCTTGTACACGTTGGGGGTGTAGTTAGTGCACGTTCTGTGA
AGCTTTTGGATCGTATCCACAATCCTGATGAACCAGAAACTCGAGATGCATGGTGGGCAGAAATCAGACA
AGAAATAAAATCACATGCTAAAGCATTAGGCTGTCATGCTGTAGTGGGCTACAGTGAATCAACTAGCATC
TGTGAAGAGGTCTGCATTTTATCTGCATCTGGCACAGCGGCTGTACTGAATCCTAGATTTCTGCAGGATG
GCACCGTGGAAGGCTGTTTGGAACAGAGGCTTGAAGAAAATTTGCCTACACGTTGTGGATTTTGTCATAT
ACCATATGATGAACTGAATATGCCATTTCCAGCTCATCTCACATATTGCTATAACTGCAGGAAACAAAAA
GTTCCTGATGTTCTGTTTACAACTATAGACCTCCCAACAGATGCAACAGTTATTGGAAAAGGTTGTCTTA
TTCAAGCAAGGTTATGTCGCTTAAAAAAGAAAGCACAGGCAGAAGCAAATGCTACAGCTATCAGTAATCT
CTTGCCATTTATGGAATATGAAGTGCATACTCAGCTAATGAATAAACTAAAACTCAAAGGAATGAATGCT
TTGTTTGGACTAAGAATTCAGATCACAGTGGGTGAAAATATGTTGATGGGCTTAGCGTCTGCCACAGGTG
TGTATTTAGCAGCTTTACCAACTCCTGGTGGTATTCAGATTGCTGGGAAGACTCCTAATGATGGCTCATA
TGAACAACACATCTCTCATATGCAGAAGAAGATAAATGACACAATTGCTAAAAACAAAGAGTTATATGAA
ATCAATCCTCCAGAGATATCTGAAGAGATTATAGGATCACCCATCCCAGAACCTAGGCAACGCTCAAGAC
TTCTAAGATCTCAATCAGAAAGCTCGGATGAAGTTACAGAATTAGACCTTTCACATGGGAAAAAAGATGC
TTTTGTTTTGGAGATTGATGACACAGATGCCATGGAAGATGTCCATTCTCTACTTACTGATGTTCCTCCT
CCTTCAGGCTTTTATAGTTGTAATACAGAAATTATGCCCGGTATAAATAATTGGACCTCTGAAATACAGA
TGTTCACTTCAGTAAGAGTAATCAGATTAAGCAGCCTCAACCTGACTAATCAAGCTCTCAATAAGAACTT
TAATGATCTCTGTGAAAATTTGCTCAAGAGCCTGTACTTTAAACTACGATCTATGATCCCCTGCTGCCTT
TGCCATGTAAATTTTACAGTATCTCTGCCTGAAGATGAATTAATTCAGGTTACAGTCACGGCAGTCGCAA
TCACTTTTGACAAAAATCAGGCTTTACAAACCACAAAAACCCCTGTTGAAAAGTCATTGCAAAGAGCCTC
AACAGATAATGAAGAACTTTTACAATTTCCACTGGAACTGTGTTCAGATTCACTTCCTTCTCATCCTTTT
CCACCAGCTAAAGAACACCTGGAGAGTGCAAGTTCTAACTCAGGTATACCAGCTGCACAGAGAGCAACGT
CAGTTGATTACAGTTCCTTTGCAGACAGATGCAGCAGCTGGATAGAGCTCATTAAACTGAAAGCTCAGAC
CATAAGGCGTGGATCAATTAAGACAACCATGACAGTTGAAAAAGCAAGTCCAGTGGGTGATGGAAATTTC
CGGAATCGTTCTGCTCCACCTTGTGCAAATTCCACAGTTGGGGTTGTTAAGATGACACCTCTTTCTTTTA
TTCCTGGAGCAAAAATAACTAAGTATCTTGGGATAATTAACATGTTTTTTATTCGAGAGACTACTTCTCT
TCGGGAGGAAGGAGGAGTCAGTGGTTTTCTCCATGCTTTTATTGCTGAAGTGTTTGCAATGGTGAGAGCT
CATGTTGCTGCATTAGGAGGGAATGCTGTTGTCTCCTACATAATGAAGCAGTGTGTCTTCATGGAGAATC
CAAATAAAAACCAGGCACAGTGTCTTATAAATGTAAGTGGTGATGCAGTGGTTTTTGTTCGTGAATCTGA
CTTAGAAGTGGTGTCATCTCAGCAACCTACTACCAACTGCCAGTCATCATGTACTGAAGGCGAAGTTACA
ACCTGA


Restriction Sites SgfI-MluI     
ACCN NM_001286176
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Note Plasmids are not sterile.  For experiments where strict sterility is required, filtration with 0.22um filter is required.
Reference Data
RefSeq NM_001286176.1, NP_001273105.1
RefSeq Size 4626 bp
RefSeq ORF 3156 bp
Locus ID 9847
UniProt ID Q86YS7
Gene Summary Required for insulin-stimulated glucose transport and glucose transporter SLC2A4/GLUT4 translocation from intracellular glucose storage vesicle (GSV) to the plasma membrane (PM) in adipocytes. Binds phospholipid membranes in a calcium-dependent manner and is necessary for the optimal membrane fusion between SLC2A4/GLUT4 GSV and the PM.[UniProtKB/Swiss-Prot Function]
Transcript Variant: This variant (1) encodes isoform a. Variants 1 and 2 encode the same isoform (a).
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...